Deutsche Bank’s Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) AST.WS Stock Holding History
Bought
Maintained
Sold
Deutsche Bank's AST.WS Position: Q3 2017 in Review
Deutsche Bank sold out of Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) (AST.WS) in Q3 2017, closing a stake of 1,920 shares.
Deutsche Bank first reported a position in AST.WS in Q2 2016 and held it in 5 quarters. The position peaked at $1K in Q4 2016. 3 funds tracked by Wall St. Rank hold AST.WS as of Q3 2017.
- Deutsche Bank reported no remaining Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position as of Q3 2017 after selling out during the quarter.
- Deutsche Bank sold 1,920 Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) shares in Q3 2017.
- Deutsche Bank first reported a position in Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) in Q2 2016 and held it in 5 quarters.
- Deutsche Bank's Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) position peaked at $1K in Q4 2016.
- 3 funds tracked by Wall St. Rank held Asterias Biotherapeutics Inc. Warrants (expiring September 29, 2017) as of Q3 2017.
Based on Deutsche Bank's 13F filing for Q3 2017, filed 14 Nov 2017.